Multifaceted Amblyopia Screening with blinq, 2WIN, and PDI Check.
Robert W ArnoldMario AngiPublished in: Clinical ophthalmology (Auckland, N.Z.) (2022)
Each device had advantages and disadvantages in screening this cohort of older, high-prevalence students, many of whom had already been treated. Validation methods should cover more than just refraction, as the new 2021 AAPOS guidelines do.